Gregory Austin Ciongoli bought $949k of RGNX
director at REGENXBIO Inc.. 102,603 shares at an average of $9.25, traded Aug 26, 2026, filed Aug 27, 2026.
Score components
- +15RoleDirector
- +24Trade size$949k at market
- +10Relative to holdingsHoldings up 665%
- +8Price context41% below the 52-week high
- 0ClusterNo other insider buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0002023732-26-000008, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Aug 25, 2026 | AGrant or award Common Stock | +15,432 | $0.00 | $0 | 15,432 | Aug 27, 2026 |
| Aug 26, 2026 | POpen-market purchase Common Stock | +49,196 | $9.14 | $450k | 64,628 | Aug 27, 2026 |
| Aug 27, 2026 | POpen-market purchase Common Stock | +53,407 | $9.36 | $500k | 118,035 | Aug 27, 2026 |
| Aug 25, 2026 | AGrant or award Stock Options (Right to buy)derivative | +69,609 | $0.00 | $0 | 69,609 | Aug 27, 2026 |
Related signals
Other insiders at REGENXBIO Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 0Weak | REGENXBIO Inc. | Steve Pakola Chief Medical Officer | $29k 2,161 shares | -1% | |
| 6Weak | REGENXBIO Inc. | Steve Pakola Chief Medical Officer | $689k 56,333 shares | -24% | |
| 6Weak | REGENXBIO Inc. | Steve Pakola Chief Medical Officer | $169k 15,309 shares | -6% | |
| 2Weak | REGENXBIO Inc. | Steve Pakola Chief Medical Officer | $53k 5,124 shares | -2% | |
| 18Weak | REGENXBIO Inc. | Curran Simpson Chief Executive Officer | $263k 20,811 shares | -9% | |
| 13Weak | REGENXBIO Inc. | Curran Simpson Chief Executive Officer | $76k 7,624 shares | -3% | |
| 13Weak | REGENXBIO Inc. | Curran Simpson Chief Executive Officer | $77k 7,734 shares | -3% | |
| 0Weak | REGENXBIO Inc. | Kenneth T. Mills President and CEO | $163k 20,602 shares | -4% | |
| 13Weak | REGENXBIO Inc. | Kenneth T. Mills President and CEO | $328k 15,000 shares | -4% | |
| 8Weak | REGENXBIO Inc. | Steve Pakola Chief Medical Officer | $365k 12,878 shares | -11% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.